EARS - Auris Medical Holding Ltd.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
0
0
0
0
Cost of Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Expenses
Research Development
3,036
6,690
19,211
24,777
Selling General and Administrative
4,393
4,265
5,150
5,412
Total Operating Expenses
7,645
10,954
24,361
30,223
Operating Income or Loss
-7,645
-10,954
-24,361
-30,223
Interest Expense
239
1,070
1,640
829
Total Other Income/Expenses Net
-2,474
690
1,521
191
Income Before Tax
-10,357
-11,334
-24,427
-30,793
Income Tax Expense
-82
162
-18
-131
Income from Continuing Operations
-10,276
-11,496
-24,409
-30,662
Net Income
-10,276
-11,496
-24,409
-30,662
Net Income available to common shareholders
-10,276
-11,496
-24,409
-30,662
Reported EPS
Basic
-
-14.40
-112.00
-178.00
Diluted
-
-14.40
-112.00
-178.00
Weighted average shares outstanding
Basic
-
795
218
172
Diluted
-
795
218
172
EBITDA
-
-10,264
-22,787
-29,867